Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31002024-01-014255falseNo description of principal activitytruetruefalse 05107064 2024-01-01 2024-12-31 05107064 2023-01-01 2023-12-31 05107064 2024-12-31 05107064 2023-12-31 05107064 c:Director1 2024-01-01 2024-12-31 05107064 c:Director5 2024-01-01 2024-12-31 05107064 c:Director5 2024-12-31 05107064 c:RegisteredOffice 2024-01-01 2024-12-31 05107064 d:PlantMachinery 2024-01-01 2024-12-31 05107064 d:PlantMachinery 2024-12-31 05107064 d:PlantMachinery 2023-12-31 05107064 d:PlantMachinery d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 05107064 d:PlantMachinery d:LeasedAssetsHeldAsLessee 2024-01-01 2024-12-31 05107064 d:OfficeEquipment 2024-01-01 2024-12-31 05107064 d:OfficeEquipment 2024-12-31 05107064 d:OfficeEquipment 2023-12-31 05107064 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 05107064 d:OfficeEquipment d:LeasedAssetsHeldAsLessee 2024-01-01 2024-12-31 05107064 d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 05107064 d:LeasedAssetsHeldAsLessee 2024-01-01 2024-12-31 05107064 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-01-01 2024-12-31 05107064 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 05107064 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-12-31 05107064 d:Goodwill 2024-01-01 2024-12-31 05107064 d:ComputerSoftware 2024-01-01 2024-12-31 05107064 d:ComputerSoftware 2024-12-31 05107064 d:ComputerSoftware 2023-12-31 05107064 d:CurrentFinancialInstruments 2024-12-31 05107064 d:CurrentFinancialInstruments 2023-12-31 05107064 d:Non-currentFinancialInstruments 2024-12-31 05107064 d:Non-currentFinancialInstruments 2023-12-31 05107064 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 05107064 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 05107064 d:Non-currentFinancialInstruments d:AfterOneYear 2024-12-31 05107064 d:Non-currentFinancialInstruments d:AfterOneYear 2023-12-31 05107064 d:ShareCapital 2024-12-31 05107064 d:ShareCapital 2023-12-31 05107064 d:SharePremium 2024-01-01 2024-12-31 05107064 d:SharePremium 2024-12-31 05107064 d:SharePremium 2023-12-31 05107064 d:CapitalRedemptionReserve 2024-01-01 2024-12-31 05107064 d:CapitalRedemptionReserve 2024-12-31 05107064 d:CapitalRedemptionReserve 2023-12-31 05107064 d:OtherMiscellaneousReserve 2024-01-01 2024-12-31 05107064 d:OtherMiscellaneousReserve 2024-12-31 05107064 d:OtherMiscellaneousReserve 2023-12-31 05107064 d:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 05107064 d:RetainedEarningsAccumulatedLosses 2024-12-31 05107064 d:RetainedEarningsAccumulatedLosses 2023-12-31 05107064 d:AcceleratedTaxDepreciationDeferredTax 2024-12-31 05107064 d:AcceleratedTaxDepreciationDeferredTax 2023-12-31 05107064 d:TaxLossesCarry-forwardsDeferredTax 2024-12-31 05107064 d:TaxLossesCarry-forwardsDeferredTax 2023-12-31 05107064 d:RetirementBenefitObligationsDeferredTax 2024-12-31 05107064 d:RetirementBenefitObligationsDeferredTax 2023-12-31 05107064 d:FurtherSpecificTypeProvisionContingentLiability1ComponentTotalProvisionsContingentLiabilities 2024-01-01 2024-12-31 05107064 d:FurtherSpecificTypeProvisionContingentLiability1ComponentTotalProvisionsContingentLiabilities 2024-12-31 05107064 c:OrdinaryShareClass1 2024-01-01 2024-12-31 05107064 c:OrdinaryShareClass1 2024-12-31 05107064 c:OrdinaryShareClass1 2023-12-31 05107064 c:OrdinaryShareClass2 2024-01-01 2024-12-31 05107064 c:OrdinaryShareClass2 2024-12-31 05107064 c:OrdinaryShareClass2 2023-12-31 05107064 c:FRS102 2024-01-01 2024-12-31 05107064 c:Audited 2024-01-01 2024-12-31 05107064 c:FullAccounts 2024-01-01 2024-12-31 05107064 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 05107064 c:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 05107064 d:DevelopmentCostsCapitalisedDevelopmentExpenditure d:ExternallyAcquiredIntangibleAssets 2024-01-01 2024-12-31 05107064 d:ComputerSoftware d:ExternallyAcquiredIntangibleAssets 2024-01-01 2024-12-31 05107064 6 2024-01-01 2024-12-31 05107064 d:ExternallyAcquiredIntangibleAssets 2024-01-01 2024-12-31 05107064 d:DevelopmentCostsCapitalisedDevelopmentExpenditure d:OwnedIntangibleAssets 2024-01-01 2024-12-31 05107064 d:ComputerSoftware d:OwnedIntangibleAssets 2024-01-01 2024-12-31 05107064 e:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 05107064









PAM WELLNESS LIMITED









FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024

 
PAM WELLNESS LIMITED
 
 
COMPANY INFORMATION


Directors
A Bones 
C Rigg (appointed 23 September 2024)




Registered number
05107064



Registered office
9 Lakeside Drive (Also known as 820 Mandarin Court)
Centre Park

Warrington

Cheshire

WA1 1GG




Independent auditors
WR Partners
Chartered Accountants & Statutory Auditors

Drake House

Gadbrook Park

Northwich

Cheshire

CW9 7RA





 
PAM WELLNESS LIMITED
 

CONTENTS



Page
Statement of financial position
 
1 - 2
Notes to the financial statements
 
3 - 13


 
PAM WELLNESS LIMITED
REGISTERED NUMBER: 05107064

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 4 
-
160,674

Tangible assets
 5 
34,431
193,017

Investments
 6 
1,758,634
1,758,634

  
1,793,065
2,112,325

Current assets
  

Stocks
  
6,311
54,007

Debtors: amounts falling due after more than one year
 7 
1,056,690
-

Debtors: amounts falling due within one year
 7 
6,173,427
5,828,503

Cash at bank and in hand
  
39,275
22,292

  
7,275,703
5,904,802

Creditors: amounts falling due within one year
 8 
(4,071,751)
(3,331,576)

Net current assets
  
 
 
3,203,952
 
 
2,573,226

Total assets less current liabilities
  
4,997,017
4,685,551

Creditors: amounts falling due after more than one year
 9 
(30,564)
(61,128)

Provisions for liabilities
  

Other provisions
 11 
(196,971)
-

  
 
 
(196,971)
 
 
-

Net assets
  
4,769,482
4,624,423


Capital and reserves
  

Called up share capital 
 12 
5,933,826
5,933,826

Share premium account
 13 
11,866,522
11,866,522

Capital redemption reserve
 13 
4,913
4,913

Other reserves
 13 
121,133
121,133

Profit and loss account
 13 
(13,156,912)
(13,301,971)

  
4,769,482
4,624,423


Page 1

 
PAM WELLNESS LIMITED
REGISTERED NUMBER: 05107064
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2024

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 25 September 2025.




A Bones
Director

The notes on pages 3 to 13 form part of these financial statements.

Page 2

 
PAM WELLNESS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

To Health Limited is a private company limited by shares incorporated in England and Wales. The registered office is 9 Lakeside Drive (Also Known As 820 Mandarin Court), Centre Park, Warrington, England, WA1 1GG.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Exemption from preparing consolidated financial statements

The Company, and the Group headed by it, qualify as small as set out in section 383 of the Companies Act 2006 and the parent and Group are considered eligible for the exemption to prepare consolidated accounts.

 
2.3

Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

Page 3

 
PAM WELLNESS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

Page 4

 
PAM WELLNESS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.7

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


 
2.8

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 The estimated useful lives range as follows:

App Development
-
20% straight Line
Computer Software
-
20% straight Line

 
2.9

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 5

 
PAM WELLNESS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


2.9
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery
-
20%
Straight Line
Office equipment
-
20%
Straight Line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.10

Impairment of fixed assets and goodwill

Assets that are subject to depreciation or amortisation are assessed at each reporting date to determine whether there is any indication that the assets are impaired. Where there is any indication that an asset may be impaired, the carrying value of the asset (or cash-generating unit to which the asset has been allocated) is tested for impairment. An impairment loss is recognised for the amount by which the asset's carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset's (or CGU's) fair value less costs to sell and value in use. For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (CGUs). Non-financial assets that have been previously impaired are reviewed at each reporting date to assess whether there is any indication that the impairment losses recognised in prior periods may no longer exist or may have decreased.

 
2.11

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each reporting date. Gains and losses on remeasurement are recognised in the Statement of income and retained earnings for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each reporting date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
2.12

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

Page 6

 
PAM WELLNESS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.13

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.14

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.15

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.16

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.17

Financial liabilities

Financial liabilities and equity are classified according to the substance of the financial instrument's contractual obligations, rather than the financial instrument's legal form.

Financial liabilities within the scope of IAS 39 are initially classified as financial liabilities at fair value through profit or loss, loans and borrowings, or as derivatives designated as hedging instruments in an effective hedge, as appropriate.
The Group determines the classification of its financial liabilities at initial recognition. All financial liabilities are recognised initially at fair value and in the case of loans and borrowings, plus directly attributable transaction costs.
Subsequently, the measurement of financial liabilities depends on their classification as follows:


3.


Employees

The average monthly number of employees, including directors, during the year was 55 (2023 - 42).

Page 7

 
PAM WELLNESS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

4.


Intangible assets




App Development
Computer software
Total

£
£
£





At 1 January 2024
110,149
142,394
252,543


Additions
-
67,440
67,440


Disposals
(110,149)
(209,834)
(319,983)



At 31 December 2024

-
-
-





At 1 January 2024
37,047
54,822
91,869


Charge for the year on owned assets
16,124
45,339
61,463


On disposals
(53,171)
(100,161)
(153,332)



At 31 December 2024

-
-
-



Net book value



At 31 December 2024
-
-
-



At 31 December 2023
73,102
87,572
160,674



Page 8

 
PAM WELLNESS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

5.


Tangible fixed assets





Plant and machinery
Office equipment
Total

£
£
£



Cost or valuation


At 1 January 2024
474,825
19,376
494,201


Additions
48,969
1,395
50,364



At 31 December 2024

523,794
20,771
544,565



Depreciation


At 1 January 2024
298,012
3,172
301,184


Charge for the year on owned assets
80,891
6,575
87,466


Charge for the year on financed assets
68,409
-
68,409


Impairment charge
43,330
9,745
53,075



At 31 December 2024

490,642
19,492
510,134



Net book value



At 31 December 2024
33,152
1,279
34,431



At 31 December 2023
176,813
16,204
193,017


6.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 January 2024
1,758,634



At 31 December 2024
1,758,634




Page 9

 
PAM WELLNESS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

7.


Debtors

2024
2023
£
£

Due after more than one year

Deferred tax asset
1,056,690
-

1,056,690
-


2024
2023
£
£

Due within one year

Trade debtors
214,460
379,633

Amounts owed by group undertakings
3,776,840
2,165,744

Prepayments and accrued income
114,871
244,215

Tax recoverable
3,221
3,221

Deferred taxation
2,064,035
3,035,690

6,173,427
5,828,503



8.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
6,097
135,492

Amounts owed to group undertakings
3,642,702
2,881,910

Other taxation and social security
65,705
107,852

Obligations under finance lease and hire purchase contracts
30,564
30,564

Other creditors
20,817
20,487

Accruals and deferred income
305,866
155,271

4,071,751
3,331,576


The obligations under finance lease and hire purchase contracts are secured against the asset to which the creditor is for.
LDC (Managers) Limited hold a fixed and and floating charge over the assets of company dated 25 June 2021.
HSBC UK Bank Plc hold a fixed and floating charge over the assets of the company dated 11 October 2016.

Page 10

 
PAM WELLNESS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

9.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Net obligations under finance leases and hire purchase contracts
30,564
61,128

30,564
61,128



10.


Deferred taxation




2024


£






At beginning of year
3,035,690


Charged to profit or loss
85,035



At end of year
3,120,725

The deferred tax asset is made up as follows:

2024
2023
£
£


Fixed asset timing difference
8,359
(23,660)

Tax losses carried forward
3,109,029
3,055,454

Movement in provisions
3,337
3,896

3,120,725
3,035,690


11.


Provisions




Other provision 1

£





Charged to profit or loss
196,971



At 31 December 2024
196,971

Page 11

 
PAM WELLNESS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

12.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



4 (2023 - 4) Ordinary shares of £3,000.00 each
12,000
12,000
592,182,610 (2023 - 592,182,610) Preferred A Ordinary shares of £0.01 each
5,921,826
5,921,826

5,933,826

5,933,826


Ordinary shares have the right to a return of capital, to receive dividends and one vote per share.
Preferred A Ordinary shares have the right to a return of capital, a right to a futher issue of Preferred A Ordinary shares at £0.01 per share where new shares issued for less that subscription price, to receive dividends and one vote per share.


13.


Reserves

Share premium account

The share premium account represents the excess paid above nominal value for the share capital issued.

Capital redemption reserve

The capital redemption reserve represents the nominal value of the share brought back by the company

Other reserves

The other reserves represent a capital contribution received from the previous owners as a result of a contractual obligation arising from the legal agreement to sell the business to PAM Occupational Health Solutions Limited.

Profit and loss account

The profit and loss account includes all current and prior periods retained profits and losses.


14.


Pension commitments

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently adminsitered fund. At 31 December 2024 the company owed £17,976 (2023: £15,884) to the pension scheme.

Page 12

 
PAM WELLNESS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

15.


Controlling party

PAM Occupational Health Solutions Limited is the immediate parent company. PAM Healthcare Limited is the ultimate parent company and the largest and smallest group in which PAM Wellness Limited is a member and for which consolidated financial statements are prepared and publicly available. A copy of the group financial statements can be obtained from PAM Healthcare Limited, 9 Lakeside Drive (Also Known As 820 Mandarin Court), Centre Park, Warrington, England, WA1 1GG.


16.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2024 was unqualified.

The audit report was signed on 26 September 2025 by Chris Speakman FCCA (Senior statutory auditor) on behalf of WR Partners.

Page 13